Methotrexate and Metformin in Rheumatoid Arthritis Patients

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

128

Participants

Timeline

Start Date

December 3, 2020

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
Arthritis, Rheumatoid
Interventions
DRUG

Metformin treatment

1500 mg once a day, per os, during six months

OTHER

Placebo

per os, during six months

DRUG

Methotrexate treatment

per os

Trial Locations (12)

Unknown

CH de la Côte Basque - service de rhumatologie, Bayonne

CHU de Bordeaux - service de rhumatologie, Bordeaux

CHU de Brest - service de rhumatologie, Brest

CH de Cahors - service de rhumatologie, Cahors

Clinique de l'Infirmerie protestante de Lyon - service de rhumatologie, Caluire-et-Cuire

CHD de Vendée - service de rhumatologie, La Roche-sur-Yon

CH du Mans - service de rhumatologie, Le Mans

CH de Libourne - service de rhumatologie, Libourne

CHU de Montpellier - service de rhumatologie, Montpellier

CHR Orléans la Source - service de rhumatologie, Orléans

CH de Pau - service de rhumatologie, Pau

CHU de Toulouse - service de rhumatolgie, Toulouse

All Listed Sponsors
collaborator

Ministry for Health and Solidarity, France

OTHER_GOV

lead

University Hospital, Bordeaux

OTHER